Exploring how prescription drugs may affect the risk of digestive cancers in older adults
Leveraging Medicare Linkages to Identify New Associations: Prescription Drugs and Digestive Cancer Risk
This study is looking at how certain prescription medications might affect the risk of digestive cancers in older adults, using a big database of Medicare and cancer information to find any connections that could help keep seniors healthier.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10425077 on NIH RePORTER |
What this research studies
This research investigates the long-term health effects of prescription drugs on older adults, particularly focusing on their potential link to digestive cancers. By utilizing a large database that includes Medicare and cancer outcome data, the study aims to identify specific prescription drugs that may influence cancer risk. The approach involves analyzing detailed prescription records and cancer diagnoses to uncover associations that are often missed in traditional clinical trials. This research is crucial for understanding the implications of medication use in aging populations, where cancer risk is heightened.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who are currently using prescription medications.
Not a fit: Patients who are younger than 65 or who do not use prescription drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed prescribing practices and improved cancer prevention strategies for older adults.
How similar studies have performed: Previous research has shown promising results in identifying drug-cancer associations using large population databases, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Du, Mengmeng — Sloan-Kettering Inst Can Research
- Study coordinator: Du, Mengmeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.